This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

MSB - Mesoblast Limited

Jump to new
well, that did not last very long
it turned very quickly and nastily,
i have my stops in the market because i do not watch it during the day, and
was stopped out 7 days into the trade
lets see where this retracement ends
 
Out at $3.09
Think it's over
 
kid hustlr said:
EOD trading hurt me on this one
Click to expand...
i average(d) 1-2 per year like this and worse for many years
i have gad to adjust and modify my trading plan
all we can do is manage the losses as best we can
and let the runnners go as far as possible
we will never pick the top or bottom
Peter
 
Currently an open profit for me (+29%) - the trend is still intact:

Maybe it ends being a +10% closed profit OR a +++100% closed profit.

#Discipline
 
Been following this in Charts of interest.



# Discipline (# Hope)
 
tech/a said:
Been following this in Charts of interest.

View attachment 71007

# Discipline (# Hope)
Click to expand...

Hi tech/a

Question:
1. Did you exit on the breaking of your trendline on Thursday?
--or--
2. Was it another trigger -- Or -- a discretionary call?
--or--
3. Was your exit a combination of the two alarm bells and another trigger not disclosed above?
 
Got out on the next bar which would have been labelled 3
actually closed it as I left the office for a meeting. Not the best exit.
As it turned out the 3 RD day had lots of volume but no reaction to BAR 2
I was pretty sure it had reached its peak---for now.
I did not expect the massive drop though.

Sometimes you get lucky.
I expect some trading now under $3

Trading on 5/5 wasn't very impressive. Buying met with supply.
Until Supply dries up this is going nowhere.
 
I'm sure you'll get the odd one but I know it's not a profitable strategy long term.
 
tech/a said:
I'm sure you'll get the odd one but I know it's not a profitable strategy long term.
Click to expand...
I systematically traded* two funds, over a combined 330 closed trades, during a period with the following notable events:
  • Commodities crash (2013 - )
  • Bloody Monday (24/08/15)
  • Chinese market crash (2016)
  • Brexit (2016)
  • Trump Dump (2016)
Closed trades annual returns (2017 set for another positive year):




According to my system (DYOR), this trend (MSB) is still well alive - I'm willing to take a loss on this one, rather than miss out on a possible large positive outlier.

Lets see what happens .

* = (one constant unchanged system + 100% disciplined trading)
 
Trendnomics said:
Currently an open profit for me (+29%) - the trend is still intact:
View attachment 71004
Maybe it ends being a +10% closed profit OR a +++100% closed profit.

#Discipline
Click to expand...
I am trying to understand your reasoning regards the trend is still intact on your chart.
Could you explain at what price level would you say the trend is broken???
 
Capital raising @$1.40

This is a hard one to pick!
 
Good results got phase 2 rheumatoid arthritis treatment.

From announcement:
Analyses were performed for the whole study population and for the pre-specified exploratory subgroups based on whether the subjects had previously received 1-2 biologic agents or more than 2 biologic agents.


Key findings:

• Infusions were well-tolerated and there were no treatment-related serious adverse events reported during the 52-week period, with the safety profile over 52 weeks comparable among the placebo and two MPC treatment groups.

• A single intravenous MPC infusion in biologic refractory RA patients resulted in dose-related improvements in clinical symptoms, function, disease activity and patient-reported outcomes. Efficacy signals were observed for each of ACR 20/50/70, ACR-N, HAQ-DI, SF-36 and DAS-28 disease activity score.

• The 2 million MPC/kg dose showed the greatest overall treatment responses. Onset of treatment responses occurred as early as 4 weeks, peaked at 12 weeks, were maintained through 39 weeks, and waned by 52 weeks.

• Greatest benefits over 52 weeks were seen in patients who had failed less than 3 biologics (1-


2 biologic sub-group) prior to MPC treatment, identifying this as a potentially optimal target population.

• The following statistically significant outcomes were observed over the 52-week study period:
 
Exciting times.
one good phase 3 results, another to follow soon, deals with bigger companies, price up 60% in two weeks.
 
Mesoblast doing very well in the last week. On 20 September the company announced continued strong survival outcomes through Day 180 in children with steroid refractory acute Graft Versus Host Disease (aGVHD) treated with Mesoblast's Phase 3 product candidate remestemcel-L.

MSB reached 12 month highs today ($2.07) and closed at $2.05, up 9.6% and near its high for the day. It's looking like it may have some more short term momentum.

 
I have taken a big position.
I believe the price will keep rising from here till March when some more phase 3 testing comes out.
 
I hope your right Knobby.
But I expect a pullback from this testing of a previous high.
If it blasts straight through and then sees the highs acting as support---
then I think you'll be in a better position.
 
You must log in or register to reply here.

Similar threads

Can you make money investing in watches?
2
Replies
29
Views
1K
moXJO
M
XJO, Gear, Spi, Overwrites & CC's (no not the chips)
2
Replies
21
Views
3K
Rosscoe62
Multiculturalism
Replies
3
Views
592
Captain_Chaza
SGD - Snowline Gold Corp. (TSX-V)
Replies
1
Views
466
mullokintyre
GMIN - G Mining Ventures Corp. (TSX)
Replies
1
Views
592
mullokintyre
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn more...